Our Orbitrap Astral Mass Spectrometer is a gold winner in the R&D 100 award – Market Disruptor category – and recognized as one the most significant advancements in mass spectrometry in 15 years. Additionally, our Gibco CTS Detachable Dynabeads platform, which is designed to help expedite manufacturing of cell therapies, was recognized in the Mechanical/Materials category. “Our ongoing innovation across the industry underscores our efforts to equip customers with the most powerful technologies and efficient workflows to tackle the world’s most complex problems and improve overall human health,” said Karen Nelson, chief scientific officer, Thermo Fisher Scientific. Learn more about our innovations: https://lnkd.in/gg-BDB78 R&D - Research & Development World
Well deserved! We need more advancements like this to reveal secrets hidden in the microscopic universe, discovering these ever-elusive protein ninjas! Researchers can now find new signs of diseases, detect them earlier, and create more effective treatments. Great job, TFS!
What an impressive groundbreaking advance in Mass Spectrometry Analysis, from Thermo Fisher Scientific and the Gibco CTS Detachable Dynabeads are an impressive technological innovation too. #Analysismakesadifference #Biotech #Pharma
Such an amazing and exciting time for science
Amazing! Congrats!
What an achievement!
Best of luck!
For what
Great post thanks for sharing
What an achievement
Senior Managing Partner
2moCongrats on that grear award. Still remember the time when we did roll out the first Orbitraps, of which i did install quite a large number. I even had the honor to install number 50, 100, 150 and 200 ( SN) at that time.